Administration of Rapidly Generated Multivirus-specific Cytotoxic T-Lymphocytes (VIRAGE)

Clinical trial NCT01070797 · COMPLETED

Trial details

NCT number: NCT01070797
Sponsor: Baylor College of Medicine
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Adenovirus Infection Epstein-Barr Virus Infections Cytomegalovirus Infections Stem Cell Transplant

Start date: 2011-01-01
Primary completion: 2013-05-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.